Trial intelligence / Profile preview

Cognitive-Motor Rehabilitation vs Ritalin in ADHD

NCT02780102Completed

Sponsor
Allameh Tabataba'i University
Start
Sep 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Allameh Tabataba'i University. Primary endpoints: Forward/backward digit span tasks (WISC-IV) at 12 months, Span board task at 12 months and 7 more. Started Sep 2015; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT02780102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02780102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call